Linaclotide for treatment of irritable bowel syndrome--the view of European regulators.

Autor: Berntgen M; European Medicines Agency, London, United Kingdom. Electronic address: michael.berntgen@ema.europa.eu., Enzmann H, Schabel E, Prieto Yerro C, Gómez-Outes A, Salmonson T, Musaus J
Jazyk: angličtina
Zdroj: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2013 Sep; Vol. 45 (9), pp. 724-6. Date of Electronic Publication: 2013 May 21.
DOI: 10.1016/j.dld.2013.03.017
Databáze: MEDLINE